ORMP Financials
Oramed Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$5.12
Market Cap
$87.22M
P/E Ratio
3.4
EPS
$1.00
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-19.06M
EPS (Diluted)
$-0.48
Balance Sheet Highlights
Total Assets
$155.28M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
-
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-8.41M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-650.5%
Net Margin
2192.6%
ROE
24.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ORMP revenue?
View ORMP's income statement for detailed revenue data.
Is ORMP profitable?
ORMP reported a loss of $19.06M in the most recent quarter. The net profit margin is 2192.6%.
What is ORMP market cap?
ORMP has a market capitalization of $87.22M, making it a small-cap stock.
Does ORMP have debt?
View ORMP's balance sheet for debt information.
What is ORMP cash flow?
Cash flow data is available in the full financial statements.